![]() | |
Clinical data | |
---|---|
Trade names | Geocillin; Pyopen |
Other names | CB[1] |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | Oral, parenteral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 30 to 40% |
Protein binding | 30 to 60% |
Metabolism | Minimal |
Elimination half-life | 1 hour |
Excretion | Renal (30 to 40%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.022.882 |
Chemical and physical data | |
Formula | C17H18N2O6S |
Molar mass | 378.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Carbenicillin is a bactericidal antibiotic belonging to the carboxypenicillin subgroup of the penicillins.[2] It was discovered by scientists at Beecham and marketed as Pyopen. It has Gram-negative coverage which includes Pseudomonas aeruginosa but limited Gram-positive coverage. The carboxypenicillins are susceptible to degradation by beta-lactamase enzymes, although they are more resistant than ampicillin to degradation. Carbenicillin is also more stable at lower pH than ampicillin.